HIGHFDA DRUG

Fresenius Kabi 5% Dextrose Injection Recalled for Lack of Sterility Assurance (2026)

Fresenius Kabi USA, LLC recalls 5% Dextrose Injection, USP 12.5 g per 250 mL in FreeFlex bags due to lack of sterility assurance. The recall covers units distributed nationwide including Alaska and Puerto Rico. Healthcare providers and patients should stop use and consult a healthcare professional.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
March 11, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
March 11, 2026
Hazard Level
HIGH
Brands
DEXTROSE, FRESENIUS KABI USA, LLC
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, ELDERLY

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
DEXTROSE, FRESENIUS KABI USA, LLC
Product type
Intravenous (IV) Dextrose Solution
Model numbers
Batch# 6402165, Exp Date: 05/30/2028.
UPC codes
65219-456, 65219-464, 65219-458, 65219-460, 65219-462, 65219-456-05, 65219-456-60, 65219-464-05 +7 more
Sizes
250 mL
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 11, 2026

  2. Reported by FDA DRUG

    April 15, 2026

  3. RecallRadar source check

    April 22, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Lack of Assurance of Sterility

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Fresenius Kabi USA, LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

5% Dextrose Injection is used to provide calories and fluid therapy in clinical settings. In 250 mL FreeFlex bags, it is designed for IV administration.

Why This Is Dangerous

Lack of sterility assurance raises risk of infection or contamination during IV treatment, which can be life-threatening in vulnerable patients.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Hospitals and clinics must audit IV fluid inventories and isolate affected lots to prevent use; patients may require alternative therapies and monitoring.

Practical Guidance

How to identify if yours is affected

  1. Check NDCs 65219-458-05 (Unit of Use) and 65219-458-30 (Unit of Sale).
  2. Verify Batch 6402165 and Exp 05/30/2028 on the unit.
  3. Inspect FreeFlex bag label for 250 mL size.

Where to find product info

FDA recall page and Fresenius Kabi communications; unit labels and lot records in pharmacy

What timeline to expect

Replacement or refund processing timelines are facility dependent; typical ranges are 2-8 weeks depending on hospital systems and supplier processes

If the manufacturer is unresponsive

  • Escalate to the hospital risk management or pharmaceutical supply chain manager
  • File a formal incident report with the hospital peer-review committee

How to prevent similar issues

  • Implement strict receiving controls for IV solutions
  • Verify sterility confirmations from suppliers
  • Maintain segregated hold areas for suspect lots
  • Educate clinical staff on recall protocols

Documentation advice

Document batch number, expiration date, lot, and efforts to contact supplier; retain correspondence and inventory reports

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: DEXTROSE; Brand owner: Fresenius Kabi USA, LLC; Product: 5% Dextrose Injection, USP 12.5 g/250 mL in 250 mL FreeFlex bag; Unit of Use NDC: 65219-458-05; Unit of Sale NDC: 65219-458-30; Batch: 6402165; Expiration: 05/30/2028; Distribution: US Nationwide, Alaska, Puerto Rico; Recall date: 2026-03-11; Status: ACTIVE.

Reported Incidents

No incident counts are provided in the source material.

Key Facts

  • 5% Dextrose Injection, USP 12.5 g/250 mL
  • Unit of Use NDC 65219-458-05
  • Unit of Sale NDC 65219-458-30

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTELDERLYPETS
Injury Types
POISONINGELECTRICALLACERATIONBURNSUFFOCATIONOTHER

Product Details

Model Numbers
Batch# 6402165
Exp Date: 05/30/2028.
UPC Codes
65219-456
65219-464
65219-458
+12 more
Affected States
ALL
Report Date
April 15, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls